Cross-border settlement for aesthetic and cosmetic clinics with a Cyprus company

Our process begins by mapping your group's legal structure and the precise corridors through which funds will move. For a Cyprus-based aesthetic clinic, this often involves settling payments from international clients or moving funds to parent or subsidiary entities in other jurisdictions. We identify the most logical settlement institution types for each leg of the journey, which may include Cyprus-based banks and EEA-licensed electronic money institutions (EMIs).

With a clear picture of the required flows, we review the associated intercompany agreements and transfer rationale documents. These must be unambiguous and ready for scrutiny by institutional compliance teams. Our role is to ensure the paperwork accurately reflects the commercial purpose of each transfer, pre-empting questions about the movement of funds. We then make formal introductions to institutions whose risk appetite aligns with the aesthetic medicine sector and the jurisdictions involved. Finally, we provide guidance on monitoring ongoing flows to ensure that any future compliance reviews are handled smoothly, preventing unnecessary freezes on your settlement accounts.

Underwriters and compliance teams focus on the legitimacy of both your clinic's operations and the fund flows themselves. They will request a complete group chart to understand the relationship between the Cypriot entity and any other connected companies. For each settlement corridor you plan to use, they require clear intercompany agreements that detail the nature of the relationship, the services being rendered, and the justification for the transfer.

The rationale is crucial; they need to see a sound business reason for moving money from one jurisdiction to another. They will assess the tax residency and ultimate beneficial ownership of each entity in the chain to ensure transparency. Expect scrutiny of your transaction volumes, frequency, and the nature of the end counterparties. For an aesthetic clinic, they will also verify your clinic's operating licence and the professional registration of your practitioners. Concerns around prepaid treatment packages, a common feature in this industry, will be addressed by reviewing your patient consent forms and refund policies to gauge potential dispute risks.

Using a Cyprus private limited company provides a credible, EU-based vehicle for international business, but it comes with specific requirements. The Central Bank of Cyprus and local banks place significant emphasis on demonstrable substance. To be seen as a legitimate Cypriot operation, your company must have genuine local management, decision-making functions, and a physical office. Simply having a registered address is insufficient for robust banking and settlement arrangements. A local director and staff are critical.

Your company is regulated by the Registrar of Companies and must maintain a public record of its ultimate beneficial owners (UBOs) and file audited annual accounts. This transparency is a key advantage when approaching financial institutions. While local banks are thorough, we often supplement their services with accounts at EEA-licensed EMIs or other regional banks that are comfortable with medical tourism flows and multi-currency settlements in EUR, USD, and other major currencies. This hybrid approach provides operational flexibility while satisfying the strict compliance standards of Cypriot authorities.

Accounts for aesthetic clinics are often declined because the application fails to build a coherent narrative. Underwriters may see a Cyprus entity handling funds from multiple countries and suspect a shell company if there isn't clear evidence of local substance and management. We prevent this by ensuring your file includes documentation of your Cypriot office, local staff, and the basis for its tax residency.

Another major reason for rejection is a vague or poorly documented transfer rationale. Without strong intercompany agreements, settlement requests can look like an attempt to obscure the source of funds. Closures often happen later, triggered by transaction patterns that don't match the activity described during onboarding. For instance, a sudden spike in high-value transfers related to prepaid packages can raise flags about potential chargeback liabilities. We help you mitigate this by presenting your business model, including the sale of treatment packages, upfront and ensuring your patient agreements and refund policies are clear, reassuring providers about your management of service-related disputes.

Establishing a robust cross-border settlement corridor for a Cyprus-based clinic typically takes between 3 and 8 weeks. This timeline covers the preparation of your file and the onboarding process at both ends of a single corridor. If multiple corridors are required (e.g., Cyprus to the UK and Cyprus to a payment processor in Asia), the work may proceed in parallel or sequentially depending on the priorities.

Onboarding begins with our detailed preparation of your corporate file, including all entity documents, licence verifications, and flow diagrams. Once introduced to the selected bank or EMI, you will complete their application and KYC process for the UBOs and directors. Maintaining the account requires proactive communication. It is vital to inform the institution of any significant changes to your business model, such as opening new clinics in other countries or altering your settlement patterns. Regular, transparent communication prevents your activity from being flagged during routine transaction monitoring, ensuring the long-term stability of your settlement facilities.